Retatrutide 238 1089-83-2 china factory high purity 99.8%

It is a triple receptor agonist at GLP-1, GIP and GCGR receptors. In Phase 2 trials, it has been shown to reduce average body weight by more than 24% in women who do not have diabetes but are in solution during pregnancy or pre-pregnancy. Retatrutide (LY3437943) acetate engages GCGR in vivo and can improve glucose tolerance in an ipGTT through either the GIP or GLP-1 receptors. Retatrutide acetate causes great body weight loss and increases energy expenditure through glucagon receptor activatio. Retatrutide acetate can be used for the research of obesity.

Dec 26, 2023 - 01:30
0 6
Retatrutide 238 1089-83-2 china factory high purity 99.8%
Retatrutide 238 1089-83-2 china factory high purity 99.8% It is a triple receptor agonist at GLP-1, GIP and GCGR receptors. In Phase 2 trials, it has been shown to reduce average body weight by more than 24% in women who do not have diabetes but are in solution during pregnancy or pre-pregnancy.

Retatrutide (LY3437943) acetate engages GCGR in vivo and can improve glucose tolerance in an ipGTT through either the GIP or GLP-1 receptors. Retatrutide acetate causes great body weight loss and increases energy expenditure through glucagon receptor activatio. Retatrutide acetate can be used for the research of obesity.



Click here for details